✦ LIBER ✦

The performance of the Italian version of ADAS in a clinical trial with Alzheimer's disease patients

✍ Scribed by Teper, A.; Rodriguez, V.; Zaragoza, S.; Lubovich, S.; Aranda, C.; Muntaabski, P.

Book ID: 124117013
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 170 KB
Volume: 15
Category: Article
ISSN: 0197-4580
DOI: 10.1016/0197-4580(94)92480-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The relationship between CRA ADAS-Cog tr

The relationship between CRA ADAS-Cog training and performance on monitoring ADAS-Cogs at clinical sites in an Alzheimer's disease clinical trial

✍ Meyer, Stephen; Perez, Magdalena; Little, Crystal; Soto, Jay; Moriarty, David 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

The clinical meaningfulness of ADAS-Cog

The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial

✍ Kenneth Rockwood; Sherri Fay; Mary Gorman; Daniel Carver; Janice E Graham 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 272 KB

A comparison of Neuropsychological Test

A comparison of Neuropsychological Test Battery (NTB) and ADAS-cog performance in an Alzheimer's disease clinical trial

✍ Black, Ronald S.; Harrison, John; Li, David; Yang, Lingfeng; Booth, Kevin; Barla 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

The Italian version of the Alzheimer's D

The Italian version of the Alzheimer's Disease Assessment Scale (ADAS): psychometric and normative characteristics from a normal aged population

✍ Mario Fioravanti; Daniele Nacca; Ann Elizabeth Buckley; Ermanno Ferrario; Olga V 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 503 KB

The ADAS-cog and clinically meaningful c

The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease

✍ Kenneth Rockwood; Sherri Fay; Mary Gorman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views

## Abstract ## Background A minimum 4‐point change at 6 months on the Alzheimer's disease assessment scale‐cognitive subscale (ADAS‐cog) is deemed clinically important, but this cut‐point has been little studied in relation to clinical meaningfulness. In an investigator‐initiated, clinical trial o

Too Many Hidden Patients. The Exclusion

Too Many Hidden Patients. The Exclusion of Individuals with Alzheimer's Disease from Alzheimer's Disease Pharmacological Clinical Trials

✍ Monica Almici; Sara Sartori; Francesca Lombardi; Cristina Bonomini; Cristina Ger 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB